Trishula Therapeutics competitive analysis

Latest publications and patents of Trishula Therapeutics New

Explore the latest publications and patents granted to Trishula Therapeutics, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Trishula Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 23, 2021

Latest PTAB cases involving Trishula Therapeutics

Discover the latest PTAB cases involving Trishula Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Trishula Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
TRISHULA THERAPEUTICS1 - - - Highly Aggressive
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 35 - - Non-Active